Biogen, Inc. (BIIB)
201.18
+15.82
(+8.53%)
USD |
NASDAQ |
Feb 06, 16:00
197.28
-3.90
(-1.94%)
After-Hours: 20:00
Biogen Price : 201.18 for Feb. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1058.18 |
| Merck & Co., Inc. | 121.93 |
| AbbVie, Inc. | 223.43 |
| Stoke Therapeutics, Inc. | 32.40 |
| Alnylam Pharmaceuticals, Inc. | 328.16 |
Price Related Metrics
| PE Ratio | 22.85 |
| PS Ratio | 3.097 |
| Price to Book Value | 1.617 |
| Price to Free Cash Flow | 15.00 |
| Earnings Yield | 4.38% |
| Market Cap | 29.51B |
| Operating PE Ratio | 12.25 |
| Normalized PE Ratio | 17.33 |